Chicago Atlantic BDC, Inc.

Chicago Atlantic BDC, Inc. is a Maryland-based externally managed business development company that provides specialty financing to companies in highly regulated and complex industries. Its core focus is direct lending to cannabis businesses, with additional investments in growth and technology, esoteric lending, and liquidity solutions where traditional lenders are often absent.

— Chicago Atlantic BDC, Inc.
%
Cannabis direct lending60% Loans and structured credit to cannabis operators across the ecosystem, typically in underserved markets.
Growth & technology lending15% Financing for software, hardware, e-commerce, and other fast-growing companies with strong growth trajectories.
Esoteric & asset-based lending15% Specialty credit backed by less conventional assets or complex structures where underwriting is highly bespoke.
Liquidity solutions10% Capital solutions for companies needing funding without equity dilution, often in complex or transitional situations.

The company lends to privately held cannabis operators that need capital but want to avoid equity dilution, and that...

  • Cannabis companiesprimary

    Privately held cannabis operators that need direct loans, structured covenants, and capital without issuing more equity.

  • Growth & technology companiessecondary

    Software, hardware, e-commerce, and direct-to-consumer businesses seeking growth capital and liquidity runway.

  • Esoteric asset-based borrowerssecondary

    Companies with non-traditional collateral or complex financing needs that require bespoke underwriting.

  • Liquidity solution borrowersemerging

    Businesses needing capital to bridge timing gaps, refinance obligations, or support operations without dilution.

The portfolio is primarily U.S.-based, with headquarters concentration across the Midwest, West, Northeast, Southeast,...

  • U.S. portfolio dominates the investment book
  • Midwest and West are the largest portfolio regions
  • Northeast, Southeast, and Southwest are also meaningful
  • Canada is a small but visible international exposure
  • Geography matters because cannabis regulation is state-specific

The company is focused on originating senior secured, covenant-protected loans in cannabis and other underserved...

01
Maintain focus on cannabis direct lendingshort-term

This is the core niche where the adviser believes pricing and covenants are most attractive due to industry complexity.

02
Grow non-cannabis specialty lendingmedium-term

Adding growth and technology or asset-based opportunities can diversify the portfolio and reduce concentration risk.

03
Preserve credit quality and downside protection

Senior secured structures, low leverage, and liquidity covenants are intended to protect capital in stressed industries.

The main company-specific risk is credit exposure to cannabis borrowers, where regulation, banking access, and...

high

Cannabis industry regulatory risk

Borrowers operate in a highly regulated market where legal changes, licensing issues, or banking constraints can affect cash flow and loan performance.

Scope
Primary portfolio focus
Materiality
high
high

Leverage and credit facility risk

The revolving credit agreement can place security interests on assets and create foreclosure risk if covenants or repayments are missed.

Scope
Company-level financing
Materiality
high
medium

Fair value volatility on private investments

Most holdings are illiquid and valued using management judgment and third-party inputs, so marks can change materially with borrower performance.

Scope
Investment portfolio
Materiality
high
medium

Concentration in underserved specialty credit

The strategy depends on niche markets where underwriting is bespoke and borrower quality can vary widely.

Scope
Portfolio construction
Materiality
medium
Fair value measurement of private loans and equity
Net asset value and unrealized gains/losses
Effective yield and prepayment accounting
Interest income and periodic earnings
RIC tax qualification and distribution requirements
Tax expense and dividend policy
Investment company accounting under Topic 946
Income statement presentation and NAV

: 28/04/2026